BioPharma Dive January 11, 2022
If Robert Califf becomes commissioner as expected, he will face a lengthy agenda as well as questions on accelerated approvals and funding.
The Food and Drug Administration finally looks set to get a new commissioner in early 2022, and the face should be familiar to many in White Oak: Robert Califf, who led the agency in the final year of Barack Obama’s presidency.
New commissioners always face a long to-do list, especially when the position goes unfilled for as long as it did this time. Janet Woodcock, who has served as acting commissioner, is an experienced leader and known quantity for her colleagues. But lacking the backing of a presidential appointment and Senate confirmation, she wasn’t in as strong a...
Today's Sponsors
Today's Sponsor